blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3216791

EP3216791 - POLYMORPHIC SUBSTANCE OF YONKENAFIL HYDROCHLORIDE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2023
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  08.04.2022
FormerGrant of patent is intended
Status updated on  24.02.2022
FormerExamination is in progress
Status updated on  04.02.2022
FormerGrant of patent is intended
Status updated on  15.11.2021
FormerExamination is in progress
Status updated on  05.06.2019
FormerRequest for examination was made
Status updated on  11.08.2017
FormerThe international publication has been made
Status updated on  15.06.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Yangtze River Pharmaceutical Group Co., Ltd.
No.1 Yangzijiangnan Road
Taizhou, Jiangsu 225321 / CN
[2017/37]
Inventor(s)01 / ZHANG, Haibo
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
02 / CHEN, Lingwu
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
03 / LU, Xianfeng
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
04 / LIANG, Huixing
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
05 / WANG, Yongfeng
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
06 / SHI, Lianyong
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
07 / LUO, Hongpeng
No.1 Yangzijiangnan Road
Taizhou Jiangsu 225321 / CN
 [2017/37]
Representative(s)Biggi, Cristina
Bugnion S.p.A.
Viale Lancetti 17
20158 Milano / IT
[2017/37]
Application number, filing date15869159.219.11.2015
[2017/37]
WO2015CN95059
Priority number, dateCN20141079960019.12.2014         Original published format: CN201410799600
[2017/37]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016095650
Date:23.06.2016
Language:ZH
[2016/25]
Type: A1 Application with search report 
No.:EP3216791
Date:13.09.2017
Language:EN
[2017/37]
Type: B1 Patent specification 
No.:EP3216791
Date:11.05.2022
Language:EN
[2022/19]
Search report(s)International search report - published on:CN23.06.2016
(Supplementary) European search report - dispatched on:EP09.08.2017
ClassificationIPC:C07D487/04, A61P1/04, A61P3/10, A61P9/04, A61P9/10, A61P11/02, A61P11/06, A61P13/10, A61P15/06, A61P17/06, A61P17/14, A61P25/02, A61P25/08, A61P25/28, A61P35/04, A61P37/08, A61K31/519, A61P1/00
[2021/47]
CPC:
C07D487/04 (EP,CN,KR,RU,US); A61K31/519 (EP,KR,RU,US); A61P1/00 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P13/08 (EP);
A61P13/10 (EP); A61P15/00 (EP); A61P15/06 (EP);
A61P15/10 (EP,RU); A61P17/00 (EP); A61P17/06 (EP);
A61P17/14 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/08 (EP); A61P25/28 (EP); A61P27/06 (EP);
A61P3/10 (EP); A61P35/04 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07B2200/13 (CN,KR,US) (-)
Former IPC [2017/37]C07D487/04, A61K31/519, A61P15/10, A61P15/00, A61P13/00, A61P9/00, A61P11/00, A61P27/06, A61P1/00, A61P25/00, A61P17/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/37]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:POLYMORPHE SUBSTANZ VON YONKENAFIL-HYDROCHLORID, HERSTELLUNGSVERFAHREN DAFÜR UND ZUSAMMENSETZUNG UND VERWENDUNG DAVON[2017/37]
English:POLYMORPHIC SUBSTANCE OF YONKENAFIL HYDROCHLORIDE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF[2017/37]
French:SUBSTANCE POLYMORPHE DE CHLORHYDRATE DE YONKENAFIL, SON PROCÉDÉ DE PRÉPARATION, COMPOSITION À BASE DE LADITE SUBSTANCE ET UTILISATION DELADITE SUBSTANCE[2017/37]
Entry into regional phase09.06.2017Translation filed 
09.06.2017National basic fee paid 
09.06.2017Search fee paid 
09.06.2017Designation fee(s) paid 
09.06.2017Examination fee paid 
Examination procedure09.06.2017Examination requested  [2017/37]
09.06.2017Date on which the examining division has become responsible
23.02.2018Amendment by applicant (claims and/or description)
11.06.2019Despatch of a communication from the examining division (Time limit: M04)
20.09.2019Reply to a communication from the examining division
09.12.2019Despatch of a communication from the examining division (Time limit: M02)
11.02.2020Reply to a communication from the examining division
16.11.2021Communication of intention to grant the patent
03.02.2022Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.02.2022Communication of intention to grant the patent
31.03.2022Fee for grant paid
31.03.2022Fee for publishing/printing paid
31.03.2022Receipt of the translation of the claim(s)
Opposition(s)14.02.2023No opposition filed within time limit [2023/16]
Fees paidRenewal fee
27.11.2017Renewal fee patent year 03
19.11.2018Renewal fee patent year 04
18.11.2019Renewal fee patent year 05
13.11.2020Renewal fee patent year 06
18.11.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.11.2015
AL11.05.2022
AT11.05.2022
CY11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
MK11.05.2022
MT11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
IE19.11.2022
LU19.11.2022
[2024/41]
Former [2024/27]HU19.11.2015
AL11.05.2022
AT11.05.2022
CY11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
MK11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
IE19.11.2022
LU19.11.2022
Former [2024/21]HU19.11.2015
AL11.05.2022
AT11.05.2022
CY11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
IE19.11.2022
LU19.11.2022
Former [2024/18]HU19.11.2015
AL11.05.2022
AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
IE19.11.2022
LU19.11.2022
Former [2023/48]AL11.05.2022
AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
IE19.11.2022
LU19.11.2022
Former [2023/37]AL11.05.2022
AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
LU19.11.2022
Former [2023/30]AL11.05.2022
AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
MC11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
Former [2023/25]AL11.05.2022
AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
RO11.05.2022
RS11.05.2022
SI11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
Former [2023/17]AL11.05.2022
AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
RO11.05.2022
RS11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
Former [2023/09]AT11.05.2022
EE11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
RO11.05.2022
RS11.05.2022
SK11.05.2022
SM11.05.2022
BG11.08.2022
IS11.09.2022
Former [2022/51]AT11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
RS11.05.2022
BG11.08.2022
IS11.09.2022
Former [2022/50]AT11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
RS11.05.2022
BG11.08.2022
Former [2022/49]AT11.05.2022
FI11.05.2022
HR11.05.2022
LT11.05.2022
LV11.05.2022
BG11.08.2022
Former [2022/47]AT11.05.2022
FI11.05.2022
LT11.05.2022
Documents cited:Search[I]EP1634883  (TIANJIN TASLY GROUP CO LTD [CN], et al) [I] 1-15 * page 14; claims 1-10; compound 1HCl *;
 [A]  - CAIRA, "Crystalline Polymorphism of Organic Compounds", TOPICS IN CURRENT CHEMIS, SPRINGER, BERLIN, DE, (19980101), vol. 198, ISSN 0340-1022, pages 163 - 208, XP008166276 [A] 1-15 * chapter 3.1; page 165 - page 166 *

DOI:   http://dx.doi.org/10.1007/3-540-69178-2_5
International search[A]CN1552714  (BEIFANG SCIENCE & TECHNOLOGY D [CN]) [A] 1-16* description, pages 19 and 20, the preparation of compound 1 *;
 [PX]CN104530054  (YANGTZE RIVER PHARM GROUP CO) [PX] 1-16 * description, paragraphs [0007]-[0030] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.